comparemela.com

Latest Breaking News On - Company or sequanamedical - Page 3 : comparemela.com

Strong data from DSR® proof-of-concept studies in heart failure published in European Journal of Heart Failure

Serial Direct Sodium Removal in Patients with Heart Failure and Diuretic Resistance Ghent, Belgium – 3 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today announces that the results from two proof-of-concept studies, RED DESERT and SAHARA, of the Company’s DSR therapy in patients with diuretic-resistant heart failure have been published in the prestigious pe

United-states
Canada
Belgium
American
Cian-crosbie
Jeffrey-testani
Yale-university
Company-or-sequanamedical
Company-premarket-approval
Serial-direct-sodium-removal
Heart-failure
Sequana-medical

Transparency Notifications from Shareholders

PRESS RELEASEREGULATED INFORMATION3 April 2024, 06:00 pm CEST Ghent, Belgium – 3 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces today that it received transparency notifications from the shareholders listed below, notifying the number of voting rights attached to shares mentioned next to their respective names in the table below. The transparency no

Canada
United-states
Vlaams-gewest
Region-flamande
Belgium
Belgian
American
Adrianus-van-herk
Company-premarket-approval
Company-or-sequanamedical
Belgian-financial-services
Sequana-medical

Sequana Medical NV: Transparency Notifications from Shareholders

Sequana Medical NV: Transparency Notifications from Shareholders
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Canada
Vlaams-gewest
Region-flamande
Belgium
United-states
American
Belgian
Adrianus-van-herk
Dennis-riedl
Belgian-financial-services
Company-or-sequanamedical
Company-premarket-approval

Transparency Notifications from Shareholders

PRESS RELEASEREGULATED INFORMATION3 April 2024, 06:00 pm CEST Ghent, Belgium – 3 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces today that it received transparency notifications from the shareholders listed below, notifying the number of voting rights attached to shares mentioned next to their respective names in the table below. The transparency no

United-states
Vlaams-gewest
Region-flamande
Belgium
Canada
Belgian
American
Adrianus-van-herk
Company-premarket-approval
Company-or-sequanamedical
Belgian-financial-services
Sequana-medical

Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES

Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Canada
Belgium
United-states
Belgian
American
Dennis-riedl
Company-or-sequanamedical
Company-premarket-approval
Euronext-brussels
Executive-share-option
Kreos-capital
Belgian-act
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.